Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial-Reference-Cited by-同舟云学术

Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial

Published:2012-01 Issue:1 Volume:14 Page:74-81
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

Lopez-Andrès Natalia¹²,Rossignol Patrick¹²³⁴,Iraqi Wafae¹²³⁴,Fay Renaud²³⁴,Nuée Josette¹²³⁴,Ghio Stefano⁵,Cleland John G.F.⁶,Zannad Faiez¹²³⁴,Lacolley Patrick¹²³⁴

Affiliation:

1. Inserm U961; Nancy Université; Nancy France

2. Inserm; Centre d'Investigation Clinique de Nancy CIC-P 9501; Vandoeuvre-les-Nancy France

3. CHU de Nancy, Department of Cardiology, Heart Failure and Hypertension Unit; Institut Lorrain du Cœur et des Vaisseaux Louis Mathieu; Vandoeuvre-Lès Nancy France

4. Nancy-Université, Faculté de Médecine; Vandoeuvre-lès-Nancy France

5. Division of Cardiology; Fondazione IRCCS Policlinico S Matteo, University Hospital; Piazzale Golgi 1 Pavia Italy

6. Department of Cardiology; University of Hull; Kingston upon Hull UK

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1093/eurjhf/hfr151/fullpdf

Reference34 articles.

1. The effect of cardiac resynchronization on morbidity and mortality in heart failure;Cleland;N Engl J Med,2005

2. Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials;Rivero-Ayerza;Eur Heart J,2006